The Indian healthcare industry is currently at around US$ 40 billion and is expected to continue growth at a CAGR of 12%. In India, healthcare spending as a proportion of total household spending is amongst the lowest (3%) in the world with current per capital spend of less than $100, but it is one of the biggest reasons for saving. The demand side driver around under penetration of healthcare systems in world’s 2nd most populated country along with gradually opening up industry machinery encouraging private sector participation. Currently around 80% of the total Indian healthcare sector forms the Private sector and this segment is expected to grow at a faster rate of around 14-16% per annum. Private healthcare space is dominated by curative segment (at around 90%) of which hospital care takes the larger share.

Apart from the significantly large domestic demand, India also has a strong presence in generic drugs manufacturing catering to both developed and developing economies. Most of the world’s leading pharmaceutical companies have also tapped into the India opportunity to cater to the domestic demand as well as a manufacturing hub for their global operations.

With our past track record of successfully executing debt, equity and advisory transactions in healthcare, we continue our focus in this segment and also being amongst the few investment advisory firms with a dedicated practice for this segment. Some of our focus areas within this segment include hospitals, medical devices, contract services, diagnostic services and pharmacy chains.